Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Meeldijk

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cell|November 1, 2002
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinBEduard Batlle, Jeffrey T Henderson, Harry Beghtel, et al.
Plos Pathogens|February 9, 2026
Cytotoxic lymphocytes counteract viral type I interferon immune evasionMichael Y Schakelaar, Liling Shan, Shuang Li, et al.
Frontiers in Oncology|June 28, 2021
Extracellular Granzyme K Modulates Angiogenesis by Regulating Soluble VEGFR1 Release From Endothelial CellsShuang Li, Christian G M van Dijk, Jan Meeldijk, et al.
Oncotargets and Therapy|August 2, 2017
Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancerMarise R Heerma van Voss, Farhad Vesuna, Guus M Bol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2014
FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cellsPeter Boross, Nadine van Montfoort, Daphne A C Stapels, et al.
Mabs|October 16, 2015
Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targetingSaskia Meyer, Maaike Nederend, J H Marco Jansen, et al.
Clinical and Experimental Rheumatology|June 8, 2019
Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritisLiling Shan, Lucas L van den Hoogen, Jan Meeldijk, et al.
Mabs|March 20, 2018
Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivoShamir R Jacobino, Maaike Nederend, J Frederiek Reijneveld, et al.
Pharmaceutical Research|December 28, 2019
Sialic Acid-Engineered IL4-10 Fusion Protein is Bioactive and Rapidly Cleared from the CirculationCristine Steen-Louws, Peter Boross, Judith Prado, et al.
Plos Pathogens|April 14, 2020
Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic mannerLiling Shan, Shuang Li, Jan Meeldijk, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cell|November 1, 2002
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinBEduard Batlle, Jeffrey T Henderson, Harry Beghtel, et al.
Plos Pathogens|February 9, 2026
Cytotoxic lymphocytes counteract viral type I interferon immune evasionMichael Y Schakelaar, Liling Shan, Shuang Li, et al.
Frontiers in Oncology|June 28, 2021
Extracellular Granzyme K Modulates Angiogenesis by Regulating Soluble VEGFR1 Release From Endothelial CellsShuang Li, Christian G M van Dijk, Jan Meeldijk, et al.
Oncotargets and Therapy|August 2, 2017
Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancerMarise R Heerma van Voss, Farhad Vesuna, Guus M Bol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2014
FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cellsPeter Boross, Nadine van Montfoort, Daphne A C Stapels, et al.
Mabs|October 16, 2015
Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targetingSaskia Meyer, Maaike Nederend, J H Marco Jansen, et al.
Clinical and Experimental Rheumatology|June 8, 2019
Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritisLiling Shan, Lucas L van den Hoogen, Jan Meeldijk, et al.
Mabs|March 20, 2018
Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivoShamir R Jacobino, Maaike Nederend, J Frederiek Reijneveld, et al.
Pharmaceutical Research|December 28, 2019
Sialic Acid-Engineered IL4-10 Fusion Protein is Bioactive and Rapidly Cleared from the CirculationCristine Steen-Louws, Peter Boross, Judith Prado, et al.
Plos Pathogens|April 14, 2020
Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic mannerLiling Shan, Shuang Li, Jan Meeldijk, et al.
Pageof 3